Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.

XECHEM SETTLES ANTITRUST LAWSUIT AGAINST BRISTOL-MEYERS SQUIBB FOR $4.2 MILLION

Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today
that it has settled its antitrust lawsuit against Bristol-Meyers Squibb Co.
for $4.2 million. Court files reveal that the case against Bristol-Meyers, which
was brought in federal district court in Chicago in 2003, was based on Xechem's
allegations that Bristol-Meyers had engaged in anticompetitive practices relating
to Xechem's efforts to manufacture and bring to market the drug paclitaxel,
a generic equivalent of Bristol's cancer drug, TAXOL(R).